Send us a text

How does one navigate the complexities of clinical trials while honoring historical contexts? Join us on MedEvidence as we sit down with Councilman Ken Amaro, who shares his experience participating in a clinical trial for cholesterol management. Motivated by the heart-wrenching loss of two close friends, Ken's story is a powerful tale of taking charge of one's health despite legitimate concerns. We discuss his initial hesitations, deeply rooted in the historical trauma of the Tuskegee syphilis study, and explore how weighing the benefits and risks can lead to informed health decisions that transcend generational mistrust.

We also discuss generic drugs, focusing on the FDA's role in ensuring their quality and safety. Specifically, we examine the journey of Rosuvastatin from a brand-name drug to a generic option, addressing common consumer worries and the significance of making well-informed healthcare choices. Tune in for a thought-provoking discussion that promises to enlighten and inspire.

Talking Topics:
🎙Tuskegee Syphilis Study
🎙Participation in Medical Research Trials
🎙Generic Drugs

Part 1 Facts Are Only Half the Picture - Release Date July 17, 2024

Part 2 Navigating Historical Trauma in Clinical Trials - Release Date July 24, 2024

Recording Date: May 24, 2024

Be a part of advancing science by participating in clinical research.

Have a question for Dr. Koren? Email him at [email protected]

Listen on Spotify
Listen on Apple Podcasts
Watch on YouTube

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
X (Formerly Twitter)
LinkedIn

Want to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Music: Storyblocks - Corporate Inspired

Thank you for listening!